![](/img/cover-not-exists.png)
553PBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR group
Gramont, A De, Henriques, J, Baruch, B, Kim, T W, Martinez-Villacampa, M, Gallego-Plazas, J, Cervantes, A, Shim, K, Jonker, D J, Guerin-Meyer, V, Mineur, L, Banzi, M, Dewdney, A, Dejthevaporn, T SirisVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz246.030
Date:
October, 2019
File:
PDF, 79 KB
2019